Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum

Clinical and Experimental Rheumatology

Volumn 27, Issue 1 SUPPL. 52, 2009, Pages

  Amoli, M M ^a,b   Miranda Filloy, J A ^c   Vazquez Rodriguez, T R ^c   Ollier, W E R ^a   Gonzalez Gay, Miguel A ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; RANTES;

ALLELE; CONTROLLED STUDY; DNA POLYMORPHISM; ERYTHEMA NODOSUM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN BIOPSY;

BIOPSY; CHEMOKINE CCL5; CHEMOKINE CXCL5; ERYTHEMA NODOSUM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; SARCOIDOSIS;

EID: 70450273201     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. GONZALEZ-GAY MA, GARCIA-PORRUAC, PUJOL RM, SALVARANI C: Erythema nodosum: a clinical approach. Clin Exp Rheumatol 2001; 19: 365-368
2. MERT A, KUMBASAR H, OZARAS R et al.: Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol 2007; 25: 563-570
3. BAGGLIONI M: Chemokines in pathology and medicine. J Intern Med 2001; 250:91-104.
4. MAKKI RF, AL SHARIF F, GONZALEZ-GAY MA, GARCIA-PORRUA C, OLLIER WE, HAJEER AH: RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 391-393
5. AMOLI MM, THOMSON W, HAJEER AH et al.: Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 2002; 29: 2367-2370 (Pubitemid 35266027)
6. AMOLI MM, OLLIER WE, GONZALEZ-GAY MA: Lack of association of epithelial cell-derived neutrophil-activating peptide (ENA)-78 gene polymorphism with susceptibility to biopsy-proven giant cell arteritis. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S40.
7. GARCIA-PORRUA C, GONZALEZ-GAY MA, VAZQUEZ-CARUNCHO M et al.: Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43:584-92. Erratum in: Arthritis Rheum 2000; 43:1061.
8. AMOLI MM, LOPEZ-AGREDA H, SUAREZ-AMOR 0, MARTIN J, OLLIER WE, GONZALEZ-GAY MA: Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population. Clin Exp Rheumatol 2007; 25: 624-626
9. AMOLI MM, DONN RP, THOMSON W et al.: Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsyproven erythema nodosum: J Rheumatol 2002; 29: 1671-1673
10. AMOLI MM, LLORCA J, GOMEZ-GIGIREY A et al.: E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Clin Exp Rheumatol 2004; 22: 230-232
11. AMOLI MM, MIRANDA-FILLOY JA, FERNANDEZ-DIAZ ML, MARTIN J, OLLIER WE, GONZALEZ-GAY MA: Interleukin-6 promoter polymorphism at position -174 in biopsy-proven patients with erythema nodosum from a defined population. Clin Exp Rheumatol 2008; 26 (Suppl. 49): S155-6.